Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hantech Bio-Technology Co., Ltd. (1294.TWO)
Yuanlin, TW
Established in 2007 and headquartered in Yuanlin, Taiwan, Hantech Bio-Technology Co., Ltd. specializes in creating, producing, and distributing health products grounded in scientific research. The company distinguishes itself through its use of various environmentally conscious pouch packaging styles for its offerings. Under OEM and ODM collaborations, Hantech provides a range of dietary supplements available in gel, liquid, and powder forms. These supplements are presented in an extensive selection of distinctive packaging shapes, such as rectangular, curved, Z-shaped, round, wine bottle-inspired, and standing pouches.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -1.26% | -2.61% | -2.00% | +6.67% | -0.51% | -4.16% | +80.90% | +114.15% | +114.15% | +114.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+4.0% Q1'26: +30.6% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%-21.5% Q1'26: +22.6% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+15.7% Q1'26: +23.1% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+22.2% ★ Q1'26: +23.1% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+25.9% ★ Q1'26: +31.5% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+3.4% Q1'26: -1.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.25× ★ Q1'26: 0.21× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|
| Revenue |
748.42M
est: 805.00M (-7.0%)
|
778.54M
est: 943.00M (-17.4%)
|
| EBITDA |
232.09M
est: 217.86M (+6.5%)
|
172.98M
est: 255.21M (-32.2%)
|
| EBIT |
200.02M
est: 184.91M (+8.2%)
|
172.98M
est: 216.61M (-20.1%)
|
| Net Income |
155.67M
est: 187.46M (-17.0%)
|
139.08M
est: 230.10M (-39.6%)
|
| SGA |
98.17M
est: 113.58M (-13.6%)
|
—
est: 133.06M (-100.0%)
|
| EPS |
6.02
est: 6.20 (-2.9%)
|
4.60
est: 7.61 (-39.6%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bizhen Yang | Deputy GM of Quality Assurance Department | — | male |
| Geng Hao Liu | Accounting Supervisor | — | — |
| Laien Li | Deputy GM of General Administration Office | — | male |
| Qihao Liu | Treasurer | — | male |
| Xie Junyang | Chief Financial Officer | — | — |
| Yulin Li | GM & Chairman | — | male |
| Yuxuan Li | Chief of Audit Section | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1294.TWO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
